| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18037095 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 780 journal articles in the PubMed database | Email to a friend | | |
| Sinsakul M, Sika M, Rodby R, et al.
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. [Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Am J Kidney Dis 2007 Dec; 50(6):946-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sheldon E, Beaulieu A, Paster Z, et al.
Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2005 Jan; 27(1):64-77.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kim MJ, Song JH, Suh JH, et al.
Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Yonsei Med J 2003 Jun 30; 44(3):463-72.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Song YW, Lee EY, Koh EM, et al.
Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial. [Journal Article, Research Support, Non-U.S. Gov't]
Clin Ther 2007 May; 29(5):862-73.
Abstract | Full Citation | Find Related Articles | | Bingham CO, Sebba AI, Rubin BR, et al.
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. [JOURNAL ARTICLE]
Rheumatology (Oxford) 2006 Aug 27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Birbara C, Ruoff G, Sheldon E, et al.
Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. [Journal Article, Randomized Controlled Trial]
Curr Med Res Opin 2006 Jan; 22(1):199-210.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Song JH, Cha SH, Lee HJ, et al.
Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease. [Journal Article]
Nephrol Dial Transplant 2006 Mar; 21(3):683-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lehmann R, Brzosko M, Kopsa P, et al.
Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Curr Med Res Opin 2005 Apr; 21(4):517-26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fleischmann R, Sheldon E, Maldonado-Cocco J, et al.
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Rheumatol 2006 Feb; 25(1):42-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
